(a) whether the National Pharmaceutical Pricing Authority (NPPA) had issued any orders on
ceiling prices of insulin in November, 2012;
(b) if so, the details thereof;
(c) whether the Department of Pharmaceuticals has given the NPPA, a deadline of two months
to revise its orders and allow the Multi-National Companies to raise the prices of imported
insulin injections; and
(d) if so, the present status of the aforesaid matter along with the steps being taken by the
Government to control the prices of medicines containing insulin?